You searched for side effects - Page 45 of 311 - Medivizor
Navigation Menu

Does tyrosine kinase inhibitors therapy after surgery benefit patients with EGFR-mutant resected NSCLC?

Does tyrosine kinase inhibitors therapy after surgery benefit patients with EGFR-mutant resected NSCLC?

Posted by on Oct 9, 2021 in Lung cancer | 0 comments

In a nutshell This study evaluated whether patients with non-small-cell lung cancer (NSCLC) having genetic mutations could benefit from epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) therapy after surgery. The data showed that EGFR-TKI therapy after surgery significantly improved survival without disease progression in...

Read More

Is osimertinib an effective treatment for EGFR-mutant advanced non-small cell lung cancer in a real-world practice?

Is osimertinib an effective treatment for EGFR-mutant advanced non-small cell lung cancer in a real-world practice?

Posted by on Oct 3, 2021 in Lung cancer | 0 comments

In a nutshell This study looked at the use of osimertinib (Tagrisso) for the treatment of EGFR-mutant advanced non-small-cell lung cancer (NSCLC) in a real-world practice. It found that osimertinib was confirmed to improve survival without cancer progressing, while the occurrence of blood clots was more common in a real-world...

Read More

Evaluating the association of physical activity and sedentary behavior with fatigue, pain, and depressive symptoms among breast cancer survivors.

Evaluating the association of physical activity and sedentary behavior with fatigue, pain, and depressive symptoms among breast cancer survivors.

Posted by on Oct 3, 2021 in Breast cancer | 0 comments

In a nutshell This study examined the association of physical activity (PA) and sedentary time (ST) with pain, fatigue, and depressive symptoms over time among survivors of breast cancer (BC). The data showed that lower ST and higher PA is associated with lower depressive symptoms in long-term survivors of BC. Some background BC is one of the most...

Read More

Evaluating the occurrence and predictors of peripheral nerve disease after breast cancer treatment.

Evaluating the occurrence and predictors of peripheral nerve disease after breast cancer treatment.

Posted by on Oct 3, 2021 in Breast cancer | 0 comments

In a nutshell This study evaluated the occurrence and clinical predictors of peripheral neuropathy (PN; nerve damage) in long-term survivors of breast cancer (BC). The data showed that PN is an important long-term consequence of taxane-based chemotherapy in survivors of BC. Some background BC is one of the most common forms of cancer in women....

Read More

Which surgical procedure for BPH is associated with persistent medication use?

Which surgical procedure for BPH is associated with persistent medication use?

Posted by on Oct 3, 2021 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study determined the percentage of men with benign prostatic hyperplasia (BPH) that still needed BPH medication after surgical therapy for lower urinary tract symptoms (LUTS). The authors concluded that laser enucleation of the prostate (LEP) had the lowest percentage of patients that still needed BPH medication. Some...

Read More

Does sacral neuromodulation with the InterStim device improve symptoms of overactive bladder?

Does sacral neuromodulation with the InterStim device improve symptoms of overactive bladder?

Posted by on Sep 26, 2021 in Overactive bladder | 0 comments

In a nutshell This study looked at the use of sacral neuromodulation (SNM) with the InterStim device in patients with overactive bladder (OAB). It found that SNM improved the symptoms of OAB over 3 years.  Some background OAB is a condition in which the bladder contracts involuntarily leading to a sudden, urgent need to urinate....

Read More

Real-world effectiveness of combining arsenic trioxide with all-trans retinoic acid in patients with acute promyelocytic leukemia.

Real-world effectiveness of combining arsenic trioxide with all-trans retinoic acid in patients with acute promyelocytic leukemia.

Posted by on Sep 26, 2021 in Leukemia | 0 comments

In a nutshell This study described the real-world effectiveness and safety of arsenic trioxide (ATO; Trisenox) combined with all-trans retinoic acid (ATRA; Vesanoid), without chemotherapy, in patients with newly diagnosed acute promyelocytic leukemia (APL). The authors concluded that a combination of ATO and ATRA showed good results for the...

Read More

Which type of stem cell transplant is best for patients with T-cell lymphoma?

Which type of stem cell transplant is best for patients with T-cell lymphoma?

Posted by on Sep 26, 2021 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study looked at the use of two types of stem cell transplant (SCT) in the treatment of T-cell lymphoma.  It found that both haploidentical and umbilical cord blood SCT were good options for these patients.  Some background T-cell lymphoma is a cancer affecting a certain type of blood cell called T-cells. T-cells are...

Read More

Which is the best approach for treating lateral lymph node metastasis in locally advanced rectal cancer?

Which is the best approach for treating lateral lymph node metastasis in locally advanced rectal cancer?

Posted by on Sep 17, 2021 in Colorectal cancer | 0 comments

In a nutshell This study evaluated the best approach for treating lateral lymph node (LLNs) metastasis in patients with locally advanced rectal cancer (LARC). The data showed that a radiation dose boost is an effective way of increasing the response rate and decreasing recurrence rates in these patients. Some background Rectal cancer (RC) is one...

Read More